Skip to content

H.R. 3248 · 118th Congress (2023–2025)

Diagnostic Lab Testing Transparency Act

This bill requires providers of clinical diagnostic laboratory tests under Medicare to publicly post certain information relating to the prices of services.

Specifically, providers must post and annually update information about the discounted cash price and the minimum and maximum negotiated rates of each test, including ancillary services. The Centers for Medicare & Medicaid Services may assess civil penalties for violations.

Show official title

To amend title XVIII of the Social Security Act to increase price transparency of clinical diagnostic laboratory tests under the Medicare program.

Expired in House committee

Derived from the legislative history, not an official disposition.

Latest actionReferred to Health

This bill’s path

This is H.R. 3248’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

  6. Expired

Sponsor
Rep. Mariannette Miller-Meeks (R-IA-1)
Cosponsors
1 cosponsor

1 original · 0 later

  1. Rep. Diana DeGette (D-CO-1)· Original · May 11, 2023
Policy area
Health
Subjects
  • Civil actions and liability
  • Health care costs and insurance
  • Medical tests and diagnostic methods

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest
    ▸ 3 committee actions · May 11, 2023 – Dec 17, 2024
    1. Referred to committee

      Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

      Sources
    2. Referred to Health

      Referred to the Subcommittee on Health.

      Sources
    3. Referred to Health

      Referred to the Subcommittee on Health.

      Sources
  3. Expired

    Introduced → Referred to House Health → No further action before the 118th Congress ended.

Committees

  1. HouseEnergy and CommerceReferred May 11, 2023
  2. HouseHealthReferred May 12, 2023
    1. May 17, 2023 · Meeting

  3. HouseWays and MeansReferred May 11, 2023
  4. HouseHealthReferred Dec 17, 2024

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (2)
  1. Diagnostic Lab Testing Transparency Act

    Display title, Short title · Introduced in House

  2. To amend title XVIII of the Social Security Act to increase price transparency of clinical diagnostic laboratory tests under the Medicare program.

    Official title · Introduced in House